Cell phone use not linked to cancer risk Long or short-term cell phone use is not associated with increased cancer risk, according to a study in the December 6 issue of the Journal of the National Cancer Institute. view more (2006-12-06)
Barrow researchers identify a new approach to detect the early progression of brain tumors Researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center recently participated in a pilot study with the Montreal Neurological Institute that suggests a certain type of MRI scanning can detect when a patient is failing brain tumor treatment before symptoms appear. view more (2008-08-29)
Do cell phones increase brain cancer risk? Major research initiatives are needed immediately to assess the possibility that using cellular phones may lead to an increased risk of brain tumors. view more (2008-10-21)
Brain tumor researchers find their 'niche' Brain tumors appear to arise from cancer stem cells (CSCs) that live within microscopic protective "niches" formed by blood vessels in the brain; and disrupting these niches is a promising strategy for eliminating the tumors and preventing them from re-growing. view more (2007-01-17)
Fly with brain tumor may shed light on cancer causing genes A study showing how the expression of genes changes when the brain tissue of fruit flies becomes cancerous is published this week in BMC Genomics. As the function of many of these genes is conserved across evolution, the researchers expect their results will help us to understand why human brain tumors develop. The causes of brain tumor... view more... (2004-04-14)
Mechanism in cells that generate malignant brain tumors may offer target for gene therapy Researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute who first isolated cancer stem cells in adult brain tumors in 2004 have now identified a molecular mechanism that is involved in the development of these cells from which malignant brain tumors may originate. view more (2008-10-27)
New Generation of Contrast Agents Provides Hope for Enhanced Brain Tumor Diagnostics In a pilot study of gadobenate dimeglumine (GD-BOPTA), the new contrast agent has yielded improved diagnostic imaging of brain tumors in magnetic resonance imaging (MRI) compared to standard contrast media. A team of researchers headed by PD Dr. Marco Essig, Division of Radiology of the Deutsches Krebsforschungszentrum (German Cancer Research... view more... (2004-05-03)
USC researchers develop new drug to target tumor cells and blood vessels Researchers at the University of Southern California have identified a new drug compound that appears to target tumor cells and surrounding blood vessels without the negative side effects typically associated with Cox-2 inhibitors. view more (2009-04-20)
Common Virus May Help Doctors Treat Deadly Brain Tumors A common human virus may prove useful in attacking the deadliest form of brain tumors, according to study conducted by researchers at Duke's Preston Robert Tisch Brain Tumor Center. view more (2007-10-23)
